We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · March 14, 2021

Entecavir vs Tenofovir for Preventing HCC in Patients With Chronic Hepatitis B

Hepatology (Baltimore, Md.)

 

Additional Info

Hepatology (Baltimore, Md.)
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients With Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Hepatology 2021 Jan 01;73(1)68-78, S Dave, S Park, MH Murad, A Barnard, L Prokop, LA Adams, S Singh, R Loomba

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading